1. Home
  2. CCB vs PHAT Comparison

CCB vs PHAT Comparison

Compare CCB & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

HOLD

Current Price

$73.43

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$10.44

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCB
PHAT
Founded
1997
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
894.0M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
CCB
PHAT
Price
$73.43
$10.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$126.67
$19.83
AVG Volume (30 Days)
92.1K
1.1M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.72
EPS
0.78
N/A
Revenue
N/A
$175,110,000.00
Revenue This Year
$96.61
$93.04
Revenue Next Year
$22.66
$58.91
P/E Ratio
$92.29
N/A
Revenue Growth
N/A
216.93
52 Week Low
$66.50
$7.61
52 Week High
$120.05
$18.31

Technical Indicators

Market Signals
Indicator
CCB
PHAT
Relative Strength Index (RSI) 55.28 46.79
Support Level $73.44 $10.02
Resistance Level $79.50 $12.99
Average True Range (ATR) 1.91 0.65
MACD 0.66 0.04
Stochastic Oscillator 99.11 61.65

Price Performance

Historical Comparison
CCB
PHAT

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: